The university hospital in Bujumbura that Burundi's national cancer plan of January 2024 lists as the country's one public chemotherapy unit and its one public pathology laboratory. The plan counts it as one of three places in the country that give chemotherapy.
Burundi's national cancer plan for 2024 to 2028 (January 2024) lists the Centre Hospitalo-Universitaire de Kamenge as the one public chemotherapy unit among three in the country, with six day-hospital beds and longer stays housed in other services; the other two units are private, at the Centre Médico-Chirurgical de Kinindo and Tanganyika Hospital. The plan says cancer can be confirmed by pathology in one public laboratory, at this hospital, where an examination cost 50,000 Burundi francs with results in one to two months, and that the laboratory has a slide-scanning microscope for telepathology. It cites a 30-year series of 4,135 cancers confirmed from 1978 to 2008, when this was the country's only pathology laboratory. ClinicalTrials.gov names the hospital as the site of an International Agency for Research on Cancer study of thermal ablation for early changes in the cervix (NCT05211271, 86 women, 2018 to 2020). OnCo has not read the hospital's own pages. The coordinates are an approximate city point for Bujumbura.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/